Literature DB >> 10535657

Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients.

A J Swanson1, M V Pantalon, K R Cohen.   

Abstract

The effect of motivational interviewing on outpatient treatment adherence among psychiatric and dually diagnosed inpatients was investigated. Subjects were 121 psychiatric inpatients, 93 (77%) of whom had concomitant substance abuse/dependence disorders, who were randomly assigned to: a) standard treatment (ST), including pharmacotherapy, individual and group psychotherapy, activities therapy, milieu treatment, and discharge planning; or b) ST plus motivational interviewing (ST+MI), which involved 15 minutes of feedback on the results of a motivational assessment early in the hospitalization, and a 1-hour motivational interview just before discharge. Interviewers utilized motivational techniques described in Miller and Rollnick (1991), such as reflective listening, discussion of treatment obstacles, and elicitation of motivational statements. Results indicated that the proportion of patients who attended their first outpatient appointment was significantly higher for the ST+MI group (47%) than for the ST group (21%; chi2 = 8.87, df = 1, p<.01) overall, and for dually diagnosed patients (42% for ST+MI vs. 16% for ST only; chi2 = 7.68, df = 1, p<.01). Therefore, brief motivational interventions show promise in improving outpatient treatment adherence among psychiatric and dually diagnosed patients.

Entities:  

Mesh:

Year:  1999        PMID: 10535657     DOI: 10.1097/00005053-199910000-00007

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  57 in total

Review 1.  MET meets the real world: design issues and clinical strategies in the Clinical Trials Network.

Authors:  Kathleen M Carroll; Chris Farentinos; Samuel A Ball; Paul Crits-Christoph; Bryce Libby; Jon Morgenstern; Jeanne L Obert; Doug Polcin; George E Woody
Journal:  J Subst Abuse Treat       Date:  2002-09

2.  Alcohol Use Among Depressed Patients: The Need for Assessment and Intervention.

Authors:  Susan E Ramsey; Patricia A Engler; Michael D Stein
Journal:  Prof Psychol Res Pr       Date:  2005-01-01

Review 3.  Recent advances in the psychotherapy of addictive disorders.

Authors:  Kathleen M Carroll
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

Review 4.  Behavioral therapies for co-occurring substance use and mood disorders.

Authors:  Kathleen M Carroll
Journal:  Biol Psychiatry       Date:  2004-11-15       Impact factor: 13.382

Review 5.  Motivational interviewing: a systematic review and meta-analysis.

Authors:  Sune Rubak; Annelli Sandbaek; Torsten Lauritzen; Bo Christensen
Journal:  Br J Gen Pract       Date:  2005-04       Impact factor: 5.386

Review 6.  Feedback interventions for college alcohol misuse: what, why and for whom?

Authors:  Scott T Walters; Clayton Neighbors
Journal:  Addict Behav       Date:  2005-01-20       Impact factor: 3.913

Review 7.  Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism?

Authors:  Robert M Roth; Mary F Brunette; Alan I Green
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

8.  A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders.

Authors:  David A Graeber; Theresa B Moyers; Gayle Griffith; Eliseo Guajardo; Scott Tonigan
Journal:  Community Ment Health J       Date:  2003-06

Review 9.  Exercise as an Adjunctive Treatment for Substance Use Disorders: Rationale and Intervention Description.

Authors:  Jeremiah Weinstock; Margaret R Farney; Noel M Elrod; Craig E Henderson; Edward P Weiss
Journal:  J Subst Abuse Treat       Date:  2016-09-09

Review 10.  The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.

Authors:  Lisa B Dixon; Faith Dickerson; Alan S Bellack; Melanie Bennett; Dwight Dickinson; Richard W Goldberg; Anthony Lehman; Wendy N Tenhula; Christine Calmes; Rebecca M Pasillas; Jason Peer; Julie Kreyenbuhl
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.